rs10410239

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_017721.5(CC2D1A):​c.1281T>C​(p.Gly427Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.245 in 1,611,382 control chromosomes in the GnomAD database, including 60,576 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.37 ( 14790 hom., cov: 30)
Exomes 𝑓: 0.23 ( 45786 hom. )

Consequence

CC2D1A
NM_017721.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -3.31

Publications

16 publications found
Variant links:
Genes affected
CC2D1A (HGNC:30237): (coiled-coil and C2 domain containing 1A) This gene encodes a transcriptional repressor that binds to a conserved 14-bp 5'-repressor element and regulates expression of the 5-hydroxytryptamine (serotonin) receptor 1A gene in neuronal cells. The DNA binding and transcriptional repressor activities of the protein are inhibited by calcium. A mutation in this gene results in a nonsyndromic form of cognitive disability (MRT3). [provided by RefSeq, Jul 2017]
CC2D1A Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • intellectual disability, autosomal recessive 3
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • autosomal recessive non-syndromic intellectual disability
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 19-13919876-T-C is Benign according to our data. Variant chr19-13919876-T-C is described in ClinVar as Benign. ClinVar VariationId is 128615.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.31 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.739 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CC2D1ANM_017721.5 linkc.1281T>C p.Gly427Gly synonymous_variant Exon 12 of 29 ENST00000318003.11 NP_060191.3 Q6P1N0-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CC2D1AENST00000318003.11 linkc.1281T>C p.Gly427Gly synonymous_variant Exon 12 of 29 1 NM_017721.5 ENSP00000313601.6 Q6P1N0-1

Frequencies

GnomAD3 genomes
AF:
0.371
AC:
56173
AN:
151536
Hom.:
14735
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.745
Gnomad AMI
AF:
0.0890
Gnomad AMR
AF:
0.361
Gnomad ASJ
AF:
0.171
Gnomad EAS
AF:
0.309
Gnomad SAS
AF:
0.288
Gnomad FIN
AF:
0.153
Gnomad MID
AF:
0.168
Gnomad NFE
AF:
0.206
Gnomad OTH
AF:
0.322
GnomAD2 exomes
AF:
0.274
AC:
68267
AN:
249124
AF XY:
0.261
show subpopulations
Gnomad AFR exome
AF:
0.756
Gnomad AMR exome
AF:
0.367
Gnomad ASJ exome
AF:
0.181
Gnomad EAS exome
AF:
0.299
Gnomad FIN exome
AF:
0.168
Gnomad NFE exome
AF:
0.207
Gnomad OTH exome
AF:
0.256
GnomAD4 exome
AF:
0.231
AC:
337799
AN:
1459732
Hom.:
45786
Cov.:
33
AF XY:
0.230
AC XY:
167054
AN XY:
726136
show subpopulations
African (AFR)
AF:
0.768
AC:
25664
AN:
33416
American (AMR)
AF:
0.367
AC:
16397
AN:
44660
Ashkenazi Jewish (ASJ)
AF:
0.183
AC:
4786
AN:
26110
East Asian (EAS)
AF:
0.280
AC:
11092
AN:
39662
South Asian (SAS)
AF:
0.263
AC:
22667
AN:
86076
European-Finnish (FIN)
AF:
0.173
AC:
9244
AN:
53368
Middle Eastern (MID)
AF:
0.219
AC:
1140
AN:
5198
European-Non Finnish (NFE)
AF:
0.208
AC:
231600
AN:
1111024
Other (OTH)
AF:
0.253
AC:
15209
AN:
60218
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
11895
23789
35684
47578
59473
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8360
16720
25080
33440
41800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.371
AC:
56292
AN:
151650
Hom.:
14790
Cov.:
30
AF XY:
0.367
AC XY:
27182
AN XY:
74118
show subpopulations
African (AFR)
AF:
0.746
AC:
30869
AN:
41380
American (AMR)
AF:
0.361
AC:
5489
AN:
15196
Ashkenazi Jewish (ASJ)
AF:
0.171
AC:
591
AN:
3462
East Asian (EAS)
AF:
0.309
AC:
1582
AN:
5118
South Asian (SAS)
AF:
0.287
AC:
1374
AN:
4794
European-Finnish (FIN)
AF:
0.153
AC:
1607
AN:
10530
Middle Eastern (MID)
AF:
0.180
AC:
53
AN:
294
European-Non Finnish (NFE)
AF:
0.206
AC:
13962
AN:
67874
Other (OTH)
AF:
0.327
AC:
684
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1359
2717
4076
5434
6793
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
474
948
1422
1896
2370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.278
Hom.:
4718
Bravo
AF:
0.403
Asia WGS
AF:
0.372
AC:
1290
AN:
3478
EpiCase
AF:
0.205
EpiControl
AF:
0.202

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Inborn genetic diseases Benign:1
Mar 11, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.59
DANN
Benign
0.47
PhyloP100
-3.3
PromoterAI
-0.0040
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.12
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10410239; hg19: chr19-14030689; COSMIC: COSV58784792; COSMIC: COSV58784792; API